The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: A multi-centre, double-blind, randomised controlled trial

References

• Kapur N, Masters IB, Newcombe P, Chang AB. The burden of disease in pediatric non-cystic fibrosis bronchiectasis. Chest. 2012;141(4):1018–24. doi:10.1378/chest.11-0679.
   PubMed Web of Science ®Google Scholar
• Chang AB, Redding GJ, Everard ML. Chronic wet cough: Protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Pediatr Pulmonol. 2008;43(6):519–31. doi:10.1002/ppul.20821.
   PubMed Web of Science ®Google Scholar
• Wurzel DF, Marchant JM, Yerkovich ST, Upham JW, Petsky HL, Smith-Vaughan H, Masters B, Buntain H, Chang AB. Protracted bacterial bronchitis in children: natural history and risk factors for bronchiectasis. Chest. 2016;150(5):1101–8. doi:10.1016/j.chest.2016.06.030.
   PubMed Web of Science ®Google Scholar
• O'Grady K-AF, Grimwood K. The likelihood of preventing respiratory exacerbations in children and adolescents with either chronic suppurative lung disease or bronchiectasis. Front Pediatr. 2017;5:58.
   PubMed Web of Science ®Google Scholar
• Kantar A, Chang AB, Shields MD, Marchant JM, Grimwood K, Grigg J, Priftis KN, Cutrera R, Midulla F, Brand PLP, Everard ML. ERS statement on protracted bacterial bronchitis in children. Eur Respir J. 2017;50(2):1602139 doi:10.1183/13993003.02139-2016.
   PubMed Web of Science ®Google Scholar
• Goyal V, Grimwood K, Marchant J, Masters IB, Chang AB. Pediatric bronchiectasis: No longer an orphan disease. Pediatr Pulmonol. 2016;51(5):450–69. doi:10.1002/ppul.23380.
   PubMed Web of Science ®Google Scholar
• Kapur N, Masters IB, Chang AB. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability? Chest. 2010;138(1):158–64.
   PubMed Web of Science ®Google Scholar
• Forsgren A, Riesbeck K, Janson H. Protein D of Haemophilus influenzae: a protective nontypeable H. influenzae antigen and a carrier for pneumococcal conjugate vaccines. Clin Infect Dis. 2008;46(5):726–31. doi:10.1086/527396.
   PubMed Web of Science ®Google Scholar
• Khan MN, Kaur R, Pichichero ME. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children. FEMS Immunol Med Microbiol. 2012;65(3):439–47. doi:10.1111/j.1574-695X.2012.00967.x.
   PubMedGoogle Scholar
• Poolman JT, Bakaletz L, Cripps A, Denoel PA, Forsgren A, Kyd J, Lobet Y. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine. 2000;19:S108–S15. doi:10.1016/S0264-410X(00)00288-7.
   PubMed Web of Science ®Google Scholar
• Teo E, House H, Lockhart K, Purchuri SN, Pushparajah J, Cripps AW, van Driel ML. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2014;(9):CD010010.
   PubMed Web of Science ®Google Scholar
• Clancy RL, Dunkley ML, Sockler J, McDonald CF. Multi-site placebo-controlled randomised clinical trial to assess protection following oral immunisation with inactivated non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease. Intern Med J. 2016;46(6):684–93. doi:10.1111/imj.13072.
   PubMed Web of Science ®Google Scholar
• Tillotson GS. Where in the world? The role of geography in antibiotic resistance and the potential impact in pulmonary infections. Postgraduate Med. 2016;128(5):449–50. doi:10.1080/00325481.2016.1185375.
   PubMed Web of Science ®Google Scholar
• Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347(7):465–71. doi:10.1056/NEJMoa012561.
   PubMed Web of Science ®Google Scholar
• Moore DP, Dagan R, Madhi SA. Respiratory viral and pneumococcal coinfection of the respiratory tract: implications of pneumococcal vaccination. Expert Rev Respir Med. 2012;6(4):451–65. doi:10.1586/ers.12.32.
   PubMed Web of Science ®Google Scholar
• Brandtzaeg P. Do salivary antibodies reliably reflect both mucosal and systemic immunity? Annals N York Acad Sci. 2007;1098:288–311. doi:10.1196/annals.1384.012.
   PubMed Web of Science ®Google Scholar
• Pizzutto SJ, Upham JW, Yerkovich ST, Chang AB. High pulmonary Levels of IL-6 and IL-1beta in children with chronic suppurative lung disease are associated with low systemic IFN-gamma production in response to non-typeable Haemophilus influenzae. PLoS One. 2015;10(6):e0129517. doi:10.1371/journal.pone.0129517.
   PubMed Web of Science ®Google Scholar
• King PT, Ngui J, Farmer MW, Hutchinson P, Holmes PW, Holdsworth SR. Cytotoxic T lymphocyte and natural killer cell responses to non-typeable Haemophilus influenzae. Clin Exp Immunol. 2008;152(3):542–51. doi:10.1111/j.1365-2249.2008.03667.x.
   PubMed Web of Science ®Google Scholar
• Pizzutto SJ, Yerkovich ST, Upham JW, Hales BJ, Thomas WR, Chang AB. Improving immunity to Haemophilus influenzae in children with chronic suppurative lung disease. Vaccine. 2015;33(2):321–6. doi:10.1016/j.vaccine.2014.11.024.
   PubMed Web of Science ®Google Scholar
• Hare KM, Leach AJ, Morris PS, Smith-Vaughan H, Torzillo P, Bauert P, Cheng AC, McDonald MI, Brown N, Chang AB, et al. Impact of recent antibiotics on nasopharyngeal carriage and lower airway infection in Indigenous Australian children with non-cystic fibrosis bronchiectasis. Int J Antimicrob Agents. 2012;40(4):365–9. doi:10.1016/j.ijantimicag.2012.05.018.
   PubMed Web of Science ®Google Scholar
• Hare KM, Smith-Vaughan HC, Chang AB, Pizzutto S, Petsky HL, McCallum GB, Leach AJ. Propensity of pneumococcal carriage serotypes to infect the lower airways of children with chronic endobronchial infections. Vaccine. 2017;35(5):747–56. doi:10.1016/j.vaccine.2016.12.059.
   PubMed Web of Science ®Google Scholar
• Hare KM, Singleton RJ, Grimwood K, Valery PC, Cheng AC, Morris PS, Leach AJ, Smith-Vaughan HC, Chatfield M, Redding G, et al. Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasis. PLoS One. 2013;8(8):e70478. doi:10.1371/journal.pone.0070478.
   PubMed Web of Science ®Google Scholar
• Hare KM, Grimwood K, Chang AB, Chatfield MD, Valery PC, Leach AJ, Smith-Vaughan HC, Morris PS, Byrnes CA, Torzillo PJ, et al. Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo. Eur J Clin Microbiol Infect Dis. 2015;34(11):2275–85. doi:10.1007/s10096-015-2480-0.
   PubMed Web of Science ®Google Scholar
• Silfverdal SA, Coremans V, Francois N, Borys D, Cleerbout J. Safety profile of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Expert Rev Vaccines. 2017;16(2):109–21. doi:10.1586/14760584.2016.1164044.
   PubMed Web of Science ®Google Scholar
• Petrovsky N. Comparative safety of vaccine adjuvants: A summary of current evidence and future needs. Drug Saf. 2015;38(11):1059–74. doi:10.1007/s40264-015-0350-4.
   PubMed Web of Science ®Google Scholar
• Valery PC, Morris PS, Byrnes CA, Grimwood K, Torzillo PJ, Bauert PA, Masters IB, Diaz A, McCallum GB, Mobberley C, et al. Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med. 2013;1(8): 610–20. doi:10.1016/S2213-2600(13)70185-1.
   PubMed Web of Science ®Google Scholar
• O'Grady KA, Grimwood K, Cripps A, Mulholland EK, Morris P, Torzillo PJ, Wood N, Smith-Vaughan H, Revell A, Wilson A, et al. Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomised controlled trial. Trials. 2013;14:282. doi:10.1186/1745-6215-14-282.
   PubMed Web of Science ®Google Scholar
• Chang AB, Newman RG, Carlin JB, Phelan PD, Robertson CF. Subjective scoring of cough in children: parent-completed vs child-completed diary cards vs an objective method. Eur Respir J. 1998;11(2):462–6. doi:10.1183/09031936.98.11020462.
   PubMed Web of Science ®Google Scholar
• Kapur N, Masters IB, Morris PS, Chang AB. Defining exacerbation in children with non-CF bronchiectasis. Pediatr Pulmonol. 2012;47:68–75 doi:10.1002/ppul.21518.
   PubMed Web of Science ®Google Scholar
• Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet. 2006;367(9512):740–8. doi:10.1016/S0140-6736(06)68304-9.
   PubMed Web of Science ®Google Scholar